FDA Expands Indication of Antiviral Therapy to Include Post-Exposure Influenza Prevention
November 23rd 2020Officials with the FDA expanded the approved indication for baloxavir marboxil (Xofluza; Genentech) to include post-exposure prevention of influenza for patients aged 12 years and older, after contact with an individual who has the flu.
NAPNAP Revises Position Statement on Integration of Mental Health Care in Primary Care Settings
October 21st 2020The revised position statement confirms that the holistic, family-centered, longitudinal approach of care delivered at the pediatric primary care level can lead to early identification of mental health issues and behavioral factors contributing to mental health issues of children.